Copy of 5 24



St. Jude-VIVA Survivorship Webinar #1:

Childhood Cancer Survivorship Care Overview

Friday, 7 Jan 2022  |  20.00 - 21:30 (UTC+8 | SGT)  |  Check your Time Zone

 Register Now


VIVA Foundation for Children with Cancer in collaboration with the St. Jude Children’s Research Hospital is excited to announce a new webinar series that will focus on childhood cancer survivorship care.  The objective of the series to is educate health care professionals about medical and psychosocial risks associated with childhood cancer and its therapy.



Lecture 1: Introduction to Late Effects
By the end of the session, attendees will be able to:

  • Appreciate how childhood cancer treatment affects long-term health
  • Understand the spectrum of late effects of childhood cancer
  • Understand the concept of risk-based survivorship care


Lecture 2: Survivorship Care Planning 

  • Understand the historical context for the development of the survivorship care plan tool
  • Describe the content and purpose of a survivorship care plan 
  • Describe models of survivorship care
  • Identify resources to guide survivorship care


If you can't make it, you can still register to receive a copy of the webinar recording.

Medical professionals in Singapore may eligible for CME/CPE/CNE credits for attending this webinar.
Credits and Certificates of Attendance will only be issued for those who are able to attend the live session and are in adherence with VIVA's Attendance Policy.




Michelle Hermiston

Dr Matthew Ehrhardt

Assistant Member,
Department of Oncology
St. Jude Children’s Research Hospital
Memphis, TN

Dr. Matthew Ehrhardt is an Assistant Member in the Division of Cancer Survivorship at St. Jude Children’s Research Hospital. Dr. Ehrhardt received his medical degree from the University of Illinois College of Medicine at Peoria and completed training in pediatrics, internal medicine, and pediatric hematology/oncology/blood and marrow transplantation at the Medical College of Wisconsin. He completed an additional year of training in childhood cancer survivorship at St. Jude Children’s Research Hospital, where he currently specializes in the care of children newly diagnosed with Hodgkin and non-Hodgkin lymphomas and long-term childhood cancer survivors. Dr. Ehrhardt’s clinical research is focused on the long-term effects of childhood cancer treatment and surveillance guideline development, dissemination, and utilization. He is currently Co-Chair of the Cardiac Task Force and Member of the Expert Panel for the Children’s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers.



Michelle Hermiston

Dr Melissa Hudson

Member, St. Jude Faculty
Director, Cancer Survivorship Division
Co-Leader, Cancer Control & Survivorship Program
The Charles E. Williams Endowed Chair of Oncology-Cancer Survivorship

Melissa M. Hudson, MD is currently a Member and Director of the Cancer Survivorship Division in the Department of Oncology at St. Jude Children’s Research Hospital where she holds the Charles E. Williams Endowed Chair of Oncology-Cancer Survivorship. She directs the After Completion of Therapy Program, which now monitors over 5000 long-term childhood cancer survivors treated on St. Jude trials. Dr. Hudson serves as Co-Chair of the Children’s Oncology Group Long-Term FollowUp Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancer and Co-Chair of the International Late Effects of Childhood Cancer Guideline Harmonization Group. She is also the Chair of the Childhood Cancer Survivor Study Education Committee. She works collaboratively with multidisciplinary investigators at St. Jude and within COG, IGHG and the CCSS in research initiatives evaluating biomedical and psychosocial outcomes among childhood cancer survivors and translating data from health outcomes research into evidence-informed clinical practice guidelines and interventions to improve the quality and duration of survival after childhood cancer. She has published widely on her research initiatives in pediatric Hodgkin lymphoma, late treatment sequelae after childhood cancer, and health education of childhood cancer survivors.